A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
Clinical trial NCT02174835 · COMPLETED
Trial details
- NCT number
- NCT02174835
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2013-11-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.